eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn's disease

Infliximab (IFX) maintenance therapy for Crohn's disease (CD) is administered every 8 weeks, but inter-patient variation in optimal treatment intervals may exist. To assess, in a prospective pilot study, the efficacy, safety and quality of life (QoL) of IFX maintenance treatment scheduled throu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 2012-11, Vol.36 (9), p.840-849
Hauptverfasser:	Pedersen, N., Elkjaer, M., Duricova, D., Burisch, J., Dobrzanski, C., Andersen, N. N., Jess, T., Bendtsen, F., Langholz, E., Leotta, S., Knudsen, T., Thorsgaard, N., Munkholm, P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - therapeutic use Biological and medical sciences Crohn Disease - drug therapy Denmark Digestive system Female Gastroenterology. Liver. Pancreas. Abdomen Gastrointestinal Agents - administration & dosage Gastrointestinal Agents - therapeutic use Health Knowledge, Attitudes, Practice Humans Infliximab Internet Male Medical sciences Middle Aged Other diseases. Semiology Patient Education as Topic Pharmacology. Drug treatments Pilot Projects Prospective Studies Self Administration - methods Self Administration - psychology Self Care - methods Self Care - psychology Severity of Illness Index Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Surveys and Questionnaires Telemedicine Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!